Skip to main content
. 2025 Apr 15;30(4):oyaf014. doi: 10.1093/oncolo/oyaf014

Table 2.

Therapeutic outcomes* at initial restaging.

PERT
(n = 188)
No PERT
(n = 313)
P-value
Received intended cycles of therapy, n (%) 155 (82.4) 236 (76.0) .08
CTC grades 3 and 4 toxicity, n (%) 14 (7.5) 29 (9.3) .60
Toxicity-related hospitalization, n (%) 11 (5.9) 13 (4.2) .28
Percent change in CA 19-9, mean (SD) -54.4 (56.9) 7.0 (453.1) .14
Radiographic response partial/stable, n (%) 161 (85.6) 245 (78.3) .09

*Adjusted for age, race, sex, ECOG, NLR, PNI, and chemotherapy.